Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Allylestrenol

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,862Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Review Update on VTAMA® (Tapinarof) for Atopic Dermatitis
    FDA Review Update on VTAMA® (Tapinarof) for Atopic Dermatitis

    05 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241105332994/en

    BUSINESSWIRE
    05 Nov 2024
    Share Share
    GE HealthCare reports third quarter 2024 financial results
    GE HealthCare reports third quarter 2024 financial results

    30 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241029247090/en

    BUSINESSWIRE
    30 Oct 2024
    Share Share
    Organon Acquires Dermavant, Including VTAMA® (tapinarof) Cream
    Organon Acquires Dermavant, Including VTAMA® (tapinarof) Cream

    28 Oct 2024

    // #N/A

    https://www.globenewswire.com/news-release/2024/10/28/2970142/34323/en/Organon-Completes-Acquisition-of-Dermavant-including-Innovative-Dermatologic-Therapy-VTAMA-tapinarof-Cream-1.html

    #N/A
    28 Oct 2024
    Share Share
    Organon Acquires Dermavant, Including VTAMA® Cream
    Organon Acquires Dermavant, Including VTAMA® Cream

    28 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241028071253/en

    BUSINESSWIRE
    28 Oct 2024
    Share Share
    Organon To Report Q3 2024 Results October 31
    Organon To Report Q3 2024 Results October 31

    09 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241009583391/en

    BUSINESSWIRE
    09 Oct 2024
    Share Share
    Primary Endpoint Met In Ph 3 Study Of Perjeta Biosimilar HLX11
    Primary Endpoint Met In Ph 3 Study Of Perjeta Biosimilar HLX11

    30 Sep 2024

    // PRESS RELEASE

    https://www.organon.com/news/primary-endpoint-met-in-phase-3-comparative-clinical-study-of-perjeta-pertuzumab-biosimilar-candidate-hlx11/

    PRESS RELEASE
    30 Sep 2024
    Share Share